Weighted Average Number of Shares Outstanding, Basic of TG THERAPEUTICS, INC. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tg Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2020 to Q3 2025.
  • Tg Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 145M shares, a 0.22% increase year-over-year.
  • Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 145M shares, a 2.37% increase from 2023.
  • Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 142M shares, a 4.83% increase from 2022.
  • Tg Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 135M shares, a 2.41% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

TG THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 145M +314K +0.22% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 147M +2.01M +1.39% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 147M +469K +0.32% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 145M +3.36M +2.37% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 145M +2.23M +1.56% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 145M +3.22M +2.28% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 146M +5.9M +4.2% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 142M +6.54M +4.83% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 143M +7.54M +5.58% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 142M +6.72M +4.99% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 140M +5.91M +4.4% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 135M +3.19M +2.41% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 135M +2.97M +2.25% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 135M +2.71M +2.05% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 134M +2.5M +1.9% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 132M 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024
Q3 2021 132M 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 132M 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 132M 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022

TG THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 145M +3.36M +2.37% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 142M +6.54M +4.83% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 135M +3.19M +2.41% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 132M +16.9M +14.6% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 115M 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.